Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin in PCI Patients with HIT/HITTS (ATBAT)
NCT00043940Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Apr 1999
- Primary completion
- Feb 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bivalirudin in heparin-induced thrombocytopenia (HIT), sponsored by The Medicines Company. Started Apr 1999; status: completed.
02
Drugs
bivalirudin
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT00043940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043940.